2017
DOI: 10.1016/j.genrep.2017.04.006
|View full text |Cite
|
Sign up to set email alerts
|

Polymorphisms of miR-196a2 (rs11614913) and miR-605 (rs2043556) confer susceptibility to gastric cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 17 publications
(10 citation statements)
references
References 78 publications
1
9
0
Order By: Relevance
“…These results are interesting and should be confirmed in future studies. Moreover, a previous study from our laboratory showed that the miR-605 rs2043556 (A > G) polymorphism confers an increased risk for the development of gastric cancer in individuals from the southeastern region of Brazil, 59 thus indicating a possible involvement of this miRNA in gastric carcinogenesis.…”
Section: Discussionmentioning
confidence: 85%
“…These results are interesting and should be confirmed in future studies. Moreover, a previous study from our laboratory showed that the miR-605 rs2043556 (A > G) polymorphism confers an increased risk for the development of gastric cancer in individuals from the southeastern region of Brazil, 59 thus indicating a possible involvement of this miRNA in gastric carcinogenesis.…”
Section: Discussionmentioning
confidence: 85%
“…Of the 65 studies, sample sizes ranged from 175 to 3,585, and publication year ranged from 2009 to 2017. In total, there were 2 acute lymphoblastic leukemia studies (Gutierrez-Camino et al, 2014 ; Hasani et al, 2014 ), 10 breast cancer studies (Hu et al, 2009 ; Catucci et al, 2010 ; Alshatwi et al, 2012 ; Bansal et al, 2014 ; Omrani et al, 2014 ; He et al, 2015 ; Qi et al, 2015 ; Dai et al, 2016 ; Afsharzadeh et al, 2017 ), 3 bladder cancer studies (Mittal et al, 2011 ; Deng et al, 2015 ; Wang et al, 2016 ), 5 colorectal cancer studies (Min et al, 2012 ; Vinci et al, 2013 ; Hu et al, 2014 ; Dikaiakos et al, 2015 ; Ying et al, 2016 ), 2 cervical squamous cell carcinoma studies (Zhou et al, 2011 ; Srivastava et al, 2017 ), 3 esophageal cancer studies (Umar et al, 2013 ; Wei et al, 2013 ; Shen et al, 2016 ), 7 gastric cancer studies (Okubo et al, 2010 ; Ahn et al, 2013 ; Wu et al, 2013 ; Pu et al, 2014 ; Cai et al, 2015 ; Poltronieri-Oliveira et al, 2017 ; Rogoveanu et al, 2017 ), 17 hepatocellular carcinoma studies (Akkiz et al, 2011 ; Kim et al, 2012 ; Xiang et al, 2012 ; Zhou et al, 2012 , 2014 ; Shan et al, 2013 ; Zou and Zhao, 2013 ; Chu et al, 2014 ; Hao et al, 2014 ; Kou et al, 2014 ; Ma et al, 2014 ; Qi et al, 2014 ; Wang et al, 2014 ; Li D. et al, 2015 ; Li X. et al, 2015 ; Yan et al, 2015 ; Zhang et al, 2016 ), 4 lung cancer studies (Tian et al, 2009 ; Vinci et al, 2011 ; Li D. et al, 2016 ), 2 oral squamous cell cancer studies (Hou et al, …”
Section: Resultsmentioning
confidence: 99%
“…With an additional filter, twenty-two articles were excluded (ten were reviews and meta-analyses, four were designed as not case-control study, three were uncorrelated to the relationship of rs3746444 with GC risk, three focused on the prognosis, one was repetitive data and one was Erratum). Finally, after a detailed filtrate, nine literatures and the current case-control study involving twelve independent studies were included [14][15][16][17][18][19][20][21][22]. In total, we recruited 3954 GC cases and 9745 controls.…”
Section: Meta-analysis Resultsmentioning
confidence: 99%
“…These contained publications were performed in Asians [14,15,[17][18][19][20] and Caucasians [16,21,22]. Three independent studies were conducted in GCA [15,16], seven were in non-GCA [14,16,[18][19][20]22], and two were in mixed [17,21]. Other detailed information was presented in Tables 4 and 5.…”
Section: Meta-analysis Resultsmentioning
confidence: 99%
See 1 more Smart Citation